Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
Β 

ORYX INTERNATIONAL GROWTH FUND LIMITED

Β INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

Β Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

Β This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

Β This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

Β Manager's Review

During the period under review, the FTSE Small Cap TR (Β£) Index returned -4.24% and the FTSE All-Share TR Index (Β£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

Β The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

Β Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

Β 24 April 2012 a total of 379,653 ordinary shares at a gross price of Β£2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

Β Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

Β 

Β 

30 June 2012Β 

31 MarchΒ 2012Β 

31 DecemberΒ 2011Β 

30 SeptemberΒ 2011Β 

30 JuneΒ 2011Β 

Β 

Β 

Β 

Β 

Β 

Β 

NAV

Β£2.93

Β£3.03

Β£2.79

Β£2.69

Β£2.96

Β 

Β 

Β 

Β 

Β 

Β 

US Dollar / Sterling Exchange Rate

Β 

1.5685

Β 

1.5978

Β 

1.5541

Β 

1.5579

Β 

1.6055

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Twenty Largest Equity Investments at 30 June 2012

Β 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

Β 

Β 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

Β 

By order of the Board

Β 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSGGUCPRUPPGUQ
Date   Source Headline
13th Jul 20157:00 amRNSAnnual Financial Report
23rd Jun 20158:56 amRNSNet Asset Value(s)
11th Jun 201511:59 amRNSHolding(s) in Company
11th Jun 20157:30 amRNSTransaction in Own Shares
10th Jun 20152:41 pmRNSHolding(s) in Company
1st Jun 201511:08 amRNSHolding(s) in Company
1st Jun 20157:15 amRNSTransaction in Own Shares
27th May 20156:00 pmRNSTransaction in Own Shares
27th May 20159:43 amRNSNet Asset Value(s)
19th May 20157:00 amRNSHolding(s) in Company
12th May 20155:15 pmRNSNotification of Major Interest in Shares
5th May 201512:15 pmRNSHolding(s) in Company
28th Apr 20153:08 pmRNSNet Asset Value(s)
14th Apr 20157:00 amRNSTransaction in Close Period
13th Apr 20154:22 pmRNSTransaction in Own Shares
31st Mar 20152:04 pmRNSHolding(s) in Company
30th Mar 201512:22 pmRNSHolding(s) in Company
26th Mar 201511:37 amRNSNet Asset Value(s)
25th Mar 201511:59 amRNSReplacement Form 8.3 - ACCUMULI PLC
24th Mar 20154:03 pmRNSTransaction in Own Shares
24th Mar 20153:36 pmRNSForm 8.3 - ACCUMULI PLC
10th Mar 201512:51 pmRNSHolding(s) in Company
17th Feb 20152:53 pmRNSNet Asset Value(s)
29th Jan 201510:15 amRNSHolding(s) in Company
22nd Jan 20153:19 pmRNSNet Asset Value(s)
22nd Jan 201510:23 amRNSHolding(s) in Company
20th Jan 20159:43 amRNSHolding(s) in Company
7th Jan 201511:46 amRNSHolding(s) in Company
19th Dec 20141:02 pmRNSNet Asset Value(s)
19th Dec 201410:53 amRNSHolding(s) in Company
9th Dec 20143:55 pmRNSHolding(s) in Company
2nd Dec 20142:02 pmRNSHolding(s) in Company
27th Nov 20147:00 amRNSHolding(s) in Company
25th Nov 20148:31 amRNSNet Asset Value(s)
24th Nov 20149:30 amRNSHalf Yearly Report
13th Nov 20141:30 pmRNSTransaction in Own Shares
29th Oct 20145:17 pmRNSNet Asset Value(s)
28th Oct 20144:00 pmRNSForm 8.3 - ALLOCATE SOFTWARE PLC
9th Oct 20144:12 pmRNSHolding(s) in Company
6th Oct 20147:00 amRNSTransactions in Close Period
2nd Oct 201411:25 amRNSHolding(s) in Company
1st Oct 20144:58 pmRNSHolding(s) in Company
30th Sep 20142:00 pmRNSTransaction in Own Shares
24th Sep 20144:18 pmRNSNet Asset Value(s)
4th Sep 20141:11 pmRNSHolding(s) in Company
1st Sep 20145:30 pmRNSHolding(s) in Company
28th Aug 20149:40 amRNSNet Asset Value(s)
27th Aug 20147:00 amRNSResult of AGM
19th Aug 20144:17 pmRNSHolding(s) in Company
12th Aug 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.